Extended dosing with CC‐486 (oral azacitidine) in patients with myeloid malignancies
暂无分享,去创建一个
K. Kolibaba | B. Skikne | John C. Morris | R. Rifkin | C. Becerra | M. Savona | E. Laille | Qian Dong | P. Conkling | E. Kingsley | A. Kellerman | S. Ukrainskyj | J. Morris | J. Morris